These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28251702)

  • 1. Kidney allograft surveillance biopsy practices across US transplant centers: A UNOS survey.
    Mehta R; Cherikh W; Sood P; Hariharan S
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28251702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell-mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study.
    Hoffmann AJ; Gibson IW; Ho J; Nickerson P; Rush D; Sharma A; Wishart D; Blydt-Hansen TD
    Pediatr Transplant; 2021 Mar; 25(2):e13870. PubMed ID: 33026135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation.
    Seifert ME; Yanik MV; Feig DI; Hauptfeld-Dolejsek V; Mroczek-Musulman EC; Kelly DR; Rosenblum F; Mannon RB
    Am J Transplant; 2018 Sep; 18(9):2189-2199. PubMed ID: 29766640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.
    Mehta R; Bhusal S; Randhawa P; Sood P; Cherukuri A; Wu C; Puttarajappa C; Hoffman W; Shah N; Mangiola M; Zeevi A; Tevar AD; Hariharan S
    Am J Transplant; 2018 Jul; 18(7):1710-1717. PubMed ID: 29247472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
    Lefaucheur C; Gosset C; Rabant M; Viglietti D; Verine J; Aubert O; Louis K; Glotz D; Legendre C; Duong Van Huyen JP; Loupy A
    Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single center experience of subclinical rejections and BK nephropathies by kidney allografts' surveillance biopsies.
    Naumnik B; Kowalewska J; Hryszko T; Glowiński J; Durlik M; Myśliwiec MC
    Adv Med Sci; 2017 Mar; 62(1):110-115. PubMed ID: 28242482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Early Clinical and Subclinical T Cell-mediated Rejection After Kidney Transplantation.
    Hoffman W; Mehta R; Jorgensen DR; Sood P; Randhawa P; Wu CM; Puttarajappa C; Shah NA; Tevar AD; Hariharan S
    Transplantation; 2019 Jul; 103(7):1457-1467. PubMed ID: 30747837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful steroid withdrawal guided by surveillance biopsies-A single-center experience.
    Wehmeier C; Hirt-Minkowski P; Amico P; Georgalis A; Hopfer H; Steiger J; Dickenmann M; Schaub S
    Clin Transplant; 2018 Mar; 32(3):e13181. PubMed ID: 29274236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management.
    Zotta F; Guzzo I; Morolli F; Diomedi-Camassei F; Dello Strologo L
    Pediatr Nephrol; 2018 Nov; 33(11):2167-2175. PubMed ID: 29980849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using computer-assisted morphometrics of 5-year biopsies to identify biomarkers of late renal allograft loss.
    Denic A; Morales MC; Park WD; Smith BH; Kremers WK; Alexander MP; Cosio FG; Rule AD; Stegall MD
    Am J Transplant; 2019 Oct; 19(10):2846-2854. PubMed ID: 30947386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.
    Heilman RL; Khamash HA; Smith ML; Chakkera HA; Moss AA; Reddy KS
    Clin Transplant; 2013; 27(5):772-80. PubMed ID: 23924146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.
    Alkadi MM; Kim J; Aull MJ; Schwartz JE; Lee JR; Watkins A; Lee JB; Dadhania DM; Seshan SV; Serur D; Kapur S; Suthanthiran M; Hartono C; Muthukumar T
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28921709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation.
    García-Carro C; Dörje C; Åsberg A; Midtvedt K; Scott H; Reinholt FP; Holdaas H; Reisaeter AV; Seron D
    Clin Transplant; 2018 Mar; 32(3):e13196. PubMed ID: 29380890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of subclinical injuries detected by protocol biopsy improves the long-term kidney allograft function: a single center prospective randomized clinical trial.
    Szederkényi E; Iványi B; Morvay Z; Szenohradszki P; Borda B; Marofka F; Kemény E; Lázár G
    Transplant Proc; 2011 May; 43(4):1239-43. PubMed ID: 21620099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients.
    Hymes LC; Greenbaum L; Amaral SG; Warshaw BL
    Pediatr Transplant; 2007 Aug; 11(5):536-9. PubMed ID: 17631023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney allograft rejection: Diagnosis and treatment practices in USA- A UNOS survey.
    Sood P; Cherikh WS; Toll AE; Mehta RB; Hariharan S
    Clin Transplant; 2021 Apr; 35(4):e14225. PubMed ID: 33455009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.
    Halloran PF; Reeve J; Akalin E; Aubert O; Bohmig GA; Brennan D; Bromberg J; Einecke G; Eskandary F; Gosset C; Duong Van Huyen JP; Gupta G; Lefaucheur C; Malone A; Mannon RB; Seron D; Sellares J; Weir M; Loupy A
    Am J Transplant; 2017 Nov; 17(11):2851-2862. PubMed ID: 28449409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Graft Surveillance Biopsy Utilization and Trends: Results From a Survey of High-Volume Transplant Centers.
    Lee DM; Abecassis MM; Friedewald JJ; Rose S; First MR
    Transplant Proc; 2020 Dec; 52(10):3085-3089. PubMed ID: 32576474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-derived cell-free DNA and renal allograft rejection in surveillance biopsies and indication biopsies.
    Chang JH; Alvarado Verduzco H; Toma K; Sritharan S; Mohan S; Husain SA
    Clin Transplant; 2022 Apr; 36(4):e14561. PubMed ID: 34913202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.